OpenAI's potential 2027 IPO delay and AI stock selloff

No one filed anything. No one announced anything. A single New York Times report, citing people involved in OpenAI's deliberations, said only that the company was leaning toward a 2027 listing rather than 2026 ^[1]. That was enough to set off a global selloff. SoftBank Group, OpenAI's second-largest external shareholder, fell over 12% - reported as a 12.53% drop to 6,246 yen, because its entire asset-revaluation story is collateralized on OpenAI's eventual public price ^[2]. In Japan, Kioxia, the AI-memory chipmaker that is the most valuable company on the Nikkei 225, slid 12% as the contagion spread to anything tagged AI ^[3].

The damage did not stop at shareholders. The two banks lined up to underwrite the deal took the hit too: Goldman Sachs fell as much as 4.8% and Morgan Stanley as much as 4.1%, pricing in underwriting fees that just got pushed a year further out ^[4]. The remarkable part is the asymmetry. A report about a preference - not a decision, not a filing change - moved tens of billions in market value across three continents in a single session. It is the clearest evidence yet of how much of the current AI rally is leveraged on one not-yet-existent IPO.

Underneath the delay is a single number OpenAI refuses to move off: $1 trillion. The reported choice is binary - go public in 2026 at a valuation below $1 trillion, or wait until 2027 for a cleaner shot at the trillion-dollar mark ^[1]. Altman reportedly called cutting that target a nonstarter, which is what makes the delay a function of pricing discipline rather than weakness, at least in the bullish read ^[5]. The gap is not trivial: OpenAI's March private round valued it at roughly $852 billion, so the trillion-dollar goal is a real stretch above where private investors last marked it ^[2].

CFO Sarah Friar reportedly pushed the 2027 timeline internally, pointing to heavy cash burn, compute commitments, and the company's readiness for the scrutiny of public reporting ^[6]. OpenAI has also said plainly that some things are simply easier to do as a private company ^[1]. So the standoff has two faces. To bulls, holding the line on $1 trillion is the move of a company that knows its own worth. To bears, refusing to list below $1 trillion while burning cash looks less like patience and more like a company that cannot yet justify the number it wants - and would rather wait than be repriced in public.

OpenAI's advisers did not have to imagine how a mega-IPO into this market would go - they watched one happen two weeks earlier. SpaceX went public on June 12, raising over $85 billion and touching a roughly $2.77 trillion debut valuation, then sliding to $153 per share ^[7]. That fade is reportedly part of what cooled OpenAI's appetite for a 2026 debut ^[1]. The lesson the advisers seem to have drawn is that retail and institutional demand for trillion-dollar AI and space listings is not bottomless, and a weak aftermarket is a worse outcome than a delay.

The deeper argument is structural, not sentimental. As Johns Hopkins's Dan Ye put it, a multi-billion-dollar company hitting the public market does not magically create new investing cash out of thin air ^[7]. Each mega-listing pulls capital out of existing holdings rather than adding to the pool, which is precisely why spacing OpenAI's debut away from SpaceX and a possible Anthropic listing matters ^[7]. If the pool of investor capital is finite, then OpenAI, SpaceX, and Anthropic are not three separate stories - they are three claims on the same wallet, and the order they arrive in decides who gets paid at full price.

The market's official reaction was a selloff; the crowd's reaction was something closer to vindication. Across finance communities the dominant read was that the delay is a forced retreat dressed up as strategic patience - the argument being that OpenAI simply cannot hit $1 trillion when its last private valuation was far lower, and would rather wait than be told so by public markets. SpaceX kept coming up as the canary, with its post-IPO slide from its peak treated as a preview of what a premature OpenAI listing would have looked like. Skeptics also pointed to SoftBank's exposure and to commentary framing the whole episode as a late-stage symptom of an AI bubble, with one prominent critic describing the sector as sitting on a series of time bombs.

There was a contrarian undercurrent too: that the delay is genuine prudence given the cash burn, that the SpaceX panic is overdone since the stock still trades above its IPO price, and that OpenAI lacks the kind of founder-brand anchor that carried SpaceX. Prediction markets captured the repricing most cleanly - traders sharply cut their implied odds of an OpenAI IPO in 2026, while one market still priced roughly 59% odds of an IPO being officially announced by March 1, 2027 ^[8]. The signal worth watching is the gap between the headline bearishness and that still-elevated medium-term probability: the crowd thinks the IPO is delayed, not dead.